NCT04117048View on ClinicalTrials.gov

INR at Home Measurement by the LabPad® Point-of-care in Patients on Vitamin K Antagonist Drugs (VKA)

NACompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

October 3, 2019

Primary Completion Date

April 3, 2020

Study Completion Date

April 3, 2020

Conditions
Vitamine K Antagonist (VKA) TreatmentInternational Normalized Ratio (INR) Measure at HomeThromboembolic Pathology
Interventions
DEVICE

LabPad® point-of-care

All at home INR measurements will be performed by the nurse using the LabPad® point-of-care

Trial Locations (1)

38160

Laboratoire ORIADE NOVIALE, Saint-Marcellin

Sponsors

Lead Sponsor

Medicalps
All Listed Sponsors
collaborator

AG2R La Mondiale

OTHER

collaborator

AVALUN

UNKNOWN

collaborator

Icadom

INDUSTRY

collaborator

ORIADE NOVIALE

UNKNOWN

collaborator

SIL-LAB INNOVATIONS

UNKNOWN

collaborator

TASDA

UNKNOWN

lead

Medicalps

OTHER